New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders.
Cancers (Basel)
; 15(9)2023 Apr 23.
Article
in En
| MEDLINE
| ID: mdl-37173889
Accumulating data have shown that molecular aberrations have the potential to trigger the development of acute leukemia, and that the routine application of novel molecular biology technologies has facilitated the development of investigational drugs which target driver genetic mutations [...].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland